The BEACONS Project: Why 746 Genes are Redefining Newborn Whole Genome Sequencing (WGS)

At a Glance: The BEACONS Project

• Objective: Integrating Whole Genome Sequencing (WGS) into public health newborn screening.
• Scope: 30,000 newborns; 746 genes; 777 actionable conditions.
• Criteria: Focus on interventions required within the first year of life.
• Implementation: Parallel run with existing NBS using Dried Blood Spots (DBS).

Executive Summary: What is the BEACONS Project?

The BEACONS (Building Evidence and Collaboration for Genomics in Nationwide Newborn Screening) project is a pioneering U.S. initiative aimed at integrating Whole Genome Sequencing (WGS) into public health newborn screening. It focuses on 746 genes linked to 777 conditions that are clinically actionable within the first year of life, setting a new global benchmark for pediatric precision medicine.

---

1. The Shift from “More Data” to “Early Actionability”

For years, the debate in newborn sequencing was about the volume of data. However, BEACONS shifts the focus to Actionability. Unlike previous studies like BabySeq, which analyzed over 4,000 genes, BEACONS prioritizes conditions where immediate intervention—such as dietary changes, enzyme replacement therapy, or gene therapy—can prevent irreversible damage.

Key Highlights of the BEACONS Initiative:

• Scale: 30,000 newborns over 3 years across 7 U.S. states/territories.
• Sample Type: Utilizing existing Dried Blood Spot (DBS) samples to minimize disruption.
• Clinical Integration: Results are fed directly back into public health labs and clinicians.

---

2. Actionable Gene Categories by Specialty

As a clinician, understanding which genes fall under your specialty is crucial. The 746 genes are categorized into 12 major clinical areas. Below is a summary for key departments:

Medical Speciality	Key Pathologies	Representative Genes
Endocrinology	Congenital Hypothyroidism, Hyperinsulinism	DUOX2, ABCC8, KCNJ11
Neurology	SMA, Early-onset Encephalopathy	SMN1, SCN1A, KCNQ2
Cardiology	Arrhythmias, Cardiomyopathy	KCNH2, SCN5A, MYH7
Immunology	SCID, Primary Immunodeficiencies	IL2RG, ADA, RAG1

---

3. How 3billion Aligns with the BEACONS Standard

For tertiary hospitals looking to implement a similar “Screening-to-Action” workflow, 3billion provides a seamless, service-based solution. We eliminate the need for complex internal infrastructure by offering:

• Comprehensive Coverage: Our WGS analysis fully encompasses the 746 BEACONS genes and beyond.
• DBS-Based Logistics: We utilize the same easy-to-ship Dried Blood Spot format used in the BEACONS study.
• Rapid Actionable Reporting: Our AI-driven variant prioritization ensures that clinicians receive results within the critical “Actionable Window.”

---

4. Conclusion: Moving Toward a National Standard

The BEACONS project is a window into the future of global newborn screening. By focusing on actionable genes, it provides a blueprint for how hospitals worldwide can reduce the diagnostic odyssey for rare diseases.

Are you ready to bring the BEACONS standard to your clinic?

The 746-gene list is iterative and evolving. Staying updated on these markers is essential for any modern pediatric specialist.

Frequently Asked Questions (FAQ)

Q1. What are the 746 genes included in the BEACONS project?

The BEACONS project includes 746 genes associated with 777 conditions that require medical intervention within the first year of life, such as SMN1 for Spinal Muscular Atrophy and ABCC8 for Congenital Hyperinsulinism.

Q2. How does the BEACONS project integrate WGS with existing newborn screening?

BEACONS uses the same Dried Blood Spot (DBS) samples collected for routine screening to perform Whole Genome Sequencing in parallel, ensuring no disruption to the established public health workflow.

Q3. What makes the BEACONS gene list different from studies like BabySeq or GUARDIAN?

Unlike BabySeq’s 4,000+ genes, the BEACONS list is strictly curated for “early actionability,” focusing only on conditions where diagnosis in the first year leads to immediate, life-saving treatment.

Q4. Can international hospitals adopt the BEACONS screening standard?

Yes, healthcare providers worldwide can implement this standard by partnering with diagnostic labs like 3billion, which offer WGS services optimized for the BEACONS actionable gene list using DBS logistics.